We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome (CHOP-OR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01171378
Recruitment Status : Unknown
Verified May 2015 by University of Oxford.
Recruitment status was:  Active, not recruiting
First Posted : July 28, 2010
Last Update Posted : May 28, 2015
Cancer Research UK
Oxford University Hospitals NHS Trust
NCRI CLL Subgroup
Information provided by (Responsible Party):
University of Oxford

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : February 2015
  Estimated Study Completion Date : April 2016